Literature DB >> 3080231

In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system.

J Magae, S Suzuki, K Nagai, M Yamasaki, K Ando, G Tamura.   

Abstract

Effects of an antitumor antibiotic, ascofuranone (AF) on the murine immune system were studied. Unlike lectins, AF did not induce any proliferative response of splenocytes. Furthermore, AF significantly inhibited proliferative response of splenocytes in response to lectins, such as concanavalin A, lipopolysaccharide, or phytohemagglutinin above 5 micrograms/ml. In concanavalin A-induced T-lymphocyte response, AF selectively inhibited the formation of interleukin 2 (IL-2) receptors, which was observed above 0.4 micrograms/ml. On the other hand, the inhibitory effect on the proliferative response to IL-2 of T-lymphocytes, which had already obtained IL-2 receptors, was observed above 10 micrograms/ml. IL-2 production of splenocytes in response to concanavalin A was also suppressed by AF above 2 micrograms/ml and only 3% of IL-2 was produced in the presence of AF, 10 micrograms/ml. However, AF-activated macrophages and their glycolysis was significantly stimulated. Activation of macrophages by AF was also confirmed by stimulation of interleukin 1 production and tumoricidal activity. However, natural killer activity of splenocytes was suppressed at the concentration where significant activation of tumoricidal activity of macrophages was observed. Therefore, AF had a dual effect on the immune system. Macrophages were activated to produce interleukin 1 and to kill tumor cells. On the other hand, functions of lymphocytes were suppressed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080231

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Ascochlorin suppresses TGF-β1-induced PAI-1 expression through the inhibition of phospho-EGFR in rat kidney fibroblast cells.

Authors:  Hyun-Ji Cho; Jeong-Han Kang; Ji-Hak Jeong; Yun-Jeong Jeong; Kwan-Kyu Park; Yoon-Yub Park; Yong-Suk Moon; Hong-Tae Kim; Il-Kyung Chung; Cheorl-Ho Kim; Hyeun-Wook Chang; Young-Chae Chang
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

2.  Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.

Authors:  Xiaoyun Dai; Kwang Seok Ahn; Chulwon Kim; Kodappully Sivaraman Siveen; Tina H Ong; Muthu K Shanmugam; Feng Li; Jizhong Shi; Alan Prem Kumar; Ling Zhi Wang; Boon Cher Goh; Junji Magae; Kam M Hui; Gautam Sethi
Journal:  Mol Oncol       Date:  2015-01-05       Impact factor: 6.603

3.  Ascofuranone inhibits lipopolysaccharide-induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-α, IL-6 and IL-1β in RAW 264.7 macrophages.

Authors:  Jun-Young Park; Tae-Wook Chung; Yun-Jeong Jeong; Choong-Hwan Kwak; Sun-Hyung Ha; Kyung-Min Kwon; Fukushi Abekura; Seung-Hak Cho; Young-Choon Lee; Ki-Tae Ha; Junji Magae; Young-Chae Chang; Cheorl-Ho Kim
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

4.  Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions.

Authors:  Yukiko Miyazaki; Daniel K Inaoka; Tomoo Shiba; Hiroyuki Saimoto; Takaya Sakura; Eri Amalia; Yasutoshi Kido; Chika Sakai; Mari Nakamura; Anthony L Moore; Shigeharu Harada; Kiyoshi Kita
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

5.  4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate.

Authors:  Tetsuya Kondo; Kenji Takeda; Ryo Muko; Akihiro Ito; Young-Chae Chang; Junji Magae; Takao Kataoka
Journal:  J Antibiot (Tokyo)       Date:  2019-02-22       Impact factor: 2.649

6.  Upregulation of AMPK by 4-O-methylascochlorin promotes autophagy via the HIF-1α expression.

Authors:  Ji-Young Seok; Yun-Jeong Jeong; Soon-Kyung Hwang; Cheorl-Ho Kim; Junji Magae; Young-Chae Chang
Journal:  J Cell Mol Med       Date:  2018-10-19       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.